-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Two products from Shijiazhuang Sihua Pharmaceutical Group—Guangxiang Pharmaceutical and Guolong Pharmaceutical—have been recognized as Provincial Manufacturing Single-Champion Products.
Category:
发布时间：2022-12-31
【概要描述】
Recently, the Hebei Provincial Department of Industry and Information Technology announced the fourth batch of provincial manufacturing Single-Champion Enterprises and Single-Champion Products. Among them, Metronidazole produced by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical Group, and Hydroxyethyl Starch produced by Hebei Guolong Pharmaceutical Co., Ltd. were both recognized as Hebei Province’s Manufacturing Single-Champion Products.
Recently, the Hebei Provincial Department of Industry and Information Technology announced the fourth batch of provincial manufacturing Single-Champion Enterprises and Single-Champion Products. Among them, Metronidazole produced by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical Group, and Hydroxyethyl Starch produced by Hebei Guolong Pharmaceutical Co., Ltd. were both recognized as Hebei Province’s Manufacturing Single-Champion Products.
In recent years, Shijiazhuang Sihua Pharmaceutical Group has fully leveraged its advantages across the entire industrial chain, aligning innovation initiatives with the needs of the value chain and actively advancing its “formulations plus active pharmaceutical ingredients” development strategy. Its subsidiaries, Guangxiang Pharmaceutical and Guolong Pharmaceutical, have continued to grow and strengthen, integrating and adopting world-leading process technologies and equipment, deepening collaboration with research institutes, and accelerating the development of specialty, high-value-added API products. These efforts have effectively promoted optimization and transformation of the product mix, thereby empowering the company’s high-quality development.
As a large-scale API industrialization base specializing in the production, R&D, and export of bulk APIs and high-value-added specialty APIs, Guangxiang Pharmaceutical has, in recent years, focused its research on the independent R&D of key specialty and high-end APIs as well as on breakthroughs in critical API synthesis technologies. The company has continuously accelerated R&D efficiency and driven further innovation in API synthesis processes, with a strong emphasis on elevating quality standards. Through ongoing process optimization, critical quality control parameters for metronidazole—such as residual solvents, related impurities, and microbial limits—have steadily improved, reaching world-class levels. As a result, the product has been recognized as a quality benchmark in Hebei Province and has served as the lead organization in developing several national standards. Guangxiang Pharmaceutical’s metronidazole products currently hold a leading market share both domestically and internationally, enjoying widespread favor among downstream customers.
Guided by the principle of high-quality development, Guolong Pharmaceutical has integrated the Group’s superior resources to tackle key technological challenges, thereby resolving critical issues in product manufacturing processes and breaking through longstanding technical bottlenecks in industry development. As a result, the company’s strengths in the R&D and production of specialty active pharmaceutical ingredients have continued to emerge, with its refined, diversified, and high-end API products garnering widespread attention and recognition from both the industry and society. Notably, the company’s hydroxyethyl starch product line is exclusively manufactured within the province and ranks among the top performers in domestic market sales.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091